Tacrolimus Injection Clinical Trials

• Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
  ClinicalTrials.gov Identifier: NCT00360685 - Recruiting
  Mucositis; Graft-Versus-Host Disease
  
• Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-Optimal Grafts
  ClinicalTrials.gov Identifier: NCT00321074 - Recruiting
  Liver Transplantation
  
• Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid
  ClinicalTrials.gov Identifier: NCT00469131 - Recruiting
  Hepatitis C; Liver Cirrhosis
  
• Comparative Study of Modified Release (MR) Tacrolimus/MMF in de novo Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00064701 - Active, not recruiting
  Kidney Transplantation
  
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00003572 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Efficacy and Safety Assessment of Cyclosporine Microemulsion C2 Monitoring Versus Tacrolimus C0 Monitoring in De Novo Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00149994 - Active, not recruiting
  Liver transplant
  
• Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006350 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00246129 - Recruiting
  Kidney Transplantation; Kidney Diseases; Kidney Failure
  
• AIRSAC Trial - Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen Versus Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00321906 - Recruiting
  Delayed Graft Function; Graft Rejection
  
• Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients with Abnormal Glucose Metabolism from Tacrolimus to Cyclosporine Micro-Emulsion
  ClinicalTrials.gov Identifier: NCT00150085 - Active, not recruiting
  Tacrolimus-associated abnormal glucose metabolism in kidney and liver transplant recipients
  
• Etanercept with Tacrolimus for Psoriasis
  ClinicalTrials.gov Identifier: NCT00134394 - Active, not recruiting
  Psoriasis
  
• Immunosuppression with Campath-1H and Tacrolimus in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00105235 - Active, not recruiting
  Liver Transplantation
  
• Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
  ClinicalTrials.gov Identifier: NCT00406393 - Recruiting
  Leukemia, Myelocytic, Acute; Leukemia, Lymphocytic, Acute; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
  ClinicalTrials.gov Identifier: NCT00125307 - Active, not recruiting
  type V (membranous) lupus nephritis
  
• Enteric-Coated Mycophenolate Sodium (EC-MPS) With Reduced-Dose Tacrolimus Versus EC-MPS With Standard-Dose Tacrolimus in Stable Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00284934 - Recruiting
  Kidney Diseases
  
• Tacrolimus: Protocol FKC-009 - Canadian Cardiology De Novo Study
  ClinicalTrials.gov Identifier: NCT00157014 - Active, not recruiting
  Heart transplantation; Cardiac transplantation; Transplantation, Cardiac; Transplantation, Heart; Grafting, Heart
  
• Reduction of Tacrolimus Dose in Association with Mycophenolate Mofetil After Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00151632 - Recruiting
  Liver Transplantation
  
• Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation with Tacrolimus and Everolimus
  ClinicalTrials.gov Identifier: NCT00117702 - Recruiting
  Graft vs Host Disease
  
• Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00252655 - Active, not recruiting
  Kidney Transplantation
  
• Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
  ClinicalTrials.gov Identifier: NCT00374803 - Active, not recruiting
  Kidney Transplant
  
• Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00403416 - Active, not recruiting
  Kidney Transplantation
  
• Fludarabine and Melphalan Followed by Tacrolimus and Methotrexate in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00121186 - Active, not recruiting
  adult Hodgkin''s lymphoma; adult non-Hodgkin''s lymphoma
  
• Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
  ClinicalTrials.gov Identifier: NCT00506922 - Active, not recruiting
  Leukemia; Lymphoma
  
• Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
  ClinicalTrials.gov Identifier: NCT00133367 - Recruiting
  Multiple Myeloma; Non-Hodgkin''s Lymphoma; Hodgkin''s Disease; Myelogenous Leukemia; Lymphoblastic Leukemia
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00166816 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00096096 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
  ClinicalTrials.gov Identifier: NCT00171496 - Active, not recruiting
  Kidney Transplant
  
• A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
  ClinicalTrials.gov Identifier: NCT00282256 - Active, not recruiting
  Liver Transplantation
  
• Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00089037 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
  ClinicalTrials.gov Identifier: NCT00282243 - Active, not recruiting
  Liver Transplantation
  
• A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00282568 - Active, not recruiting
  Kidney Transplantation
  
• Alemtuzumab, Tacrolimus, and Methylprednisolone in Treating Acute Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00109993 - Active, not recruiting
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Graft Versus Host Disease; hematopoietic and lymphoid cancer; Neuroblastoma
  
• Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00567918 - Active, not recruiting
  Keratoconjunctivitis; Conjunctivitis
  
• A Study of Thymoglobulin and Tacrolimus in Liver Transplant
  ClinicalTrials.gov Identifier: NCT00564538 - Enrolling by invitation
  Liver Transplantation; Liver Disease; Immunosuppression
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus
  ClinicalTrials.gov Identifier: NCT00166829 - Recruiting
  Kidney Transplantation
  
• Interaction Between Rimonabant and Cyclosporine and Tacrolimus
  ClinicalTrials.gov Identifier: NCT00525681 - Recruiting
  Renal Transplantation
  
• Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
  ClinicalTrials.gov Identifier: NCT00443105 - Active, not recruiting
  Allergic Conjunctivitis
  
• Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
  ClinicalTrials.gov Identifier: NCT00295594 - Active, not recruiting
  Liver Transplantation
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.
  ClinicalTrials.gov Identifier: NCT00296361 - Active, not recruiting
  Kidney Transplantation
  
• A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis
  ClinicalTrials.gov Identifier: NCT00569101 - Active, not recruiting
  Lupus Nephritis
  
• Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
  ClinicalTrials.gov Identifier: NCT00325325 - Recruiting
  Kidney Diseases
  
• Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
  ClinicalTrials.gov Identifier: NCT00295607 - Active, not recruiting
  Hepatitis C; Liver Transplantation
  
• Prednisone and Either Cyclosporine or Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00089141 - Recruiting
  Cancer; Graft Versus Host Disease
  
• MGA031, Sirolimus and Tacrolimus in Islet Transplantation
  ClinicalTrials.gov Identifier: NCT00265473 - Recruiting
  Type 1 Diabetes Mellitus; Hypoglycemia
  
• Effectiveness and Safety of Campath in Combination with Tacrolimus Monotherapy to Prevent Kidney Graft Rejection
  ClinicalTrials.gov Identifier: NCT00147381 - Active, not recruiting
  Kidney Transplantation
  
• Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-Coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus
  ClinicalTrials.gov Identifier: NCT00171392 - Active, not recruiting
  Prevention of Acute Rejection After Kidney Transplantation
  
• Safety/Efficacy of Induction Agents with Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00113269 - Active, not recruiting
  Kidney Transplantation
  
• Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
  ClinicalTrials.gov Identifier: NCT00296309 - Active, not recruiting
  Kidney Transplantation
  
• Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
  ClinicalTrials.gov Identifier: NCT00321113 - Recruiting
  Kidney Transplantation
  
• Efficacy and Safety of Sirolimus in Combination with Tacrolimus
  ClinicalTrials.gov Identifier: NCT00141804 - Active, not recruiting
  Kidney Transplantation
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Bortezomib Plus Tacrolimus and Methotrexate to Prevent GVHD After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00369226 - Recruiting
  Hematologic Malignancies
  
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00023244 - Active, not recruiting
  End-Stage Renal Disease
  
• Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-Myeloablative Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00282282 - Recruiting
  Graft Versus Host Disease; GVHD
  
• Suppressing the Immune System With or Without Steroids in Children Who Have Received Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00141037 - Active, not recruiting
  Kidney Diseases; Kidney Transplantation
  
• Investigation in Myositis-Associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
  ClinicalTrials.gov Identifier: NCT00504348 - Recruiting
  Interstitial Pneumonitis; Polymyositis; Dermatomyositis
  
• Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With No Steroids
  ClinicalTrials.gov Identifier: NCT00170053 - Recruiting
  Kidney Diseases
  
• TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic
  ClinicalTrials.gov Identifier: NCT00552201 - Recruiting
  Kidney Transplantation
  
• The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00275535 - Recruiting
  Kidney Diseases
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Combination Therapy to Prevent Kidney Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00078559 - Active, not recruiting
  Kidney Transplantation
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
  ClinicalTrials.gov Identifier: NCT00402168 - Recruiting
  Renal Transplant
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-Transplant
  ClinicalTrials.gov Identifier: NCT00171717 - Active, not recruiting
  Maintenance Liver Transplant Patients With New Onset Diabetes
  
• Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00134017 - Recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; plasma cell neoplasm
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• Pre-Transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00297310 - Completed
  Kidney Transplantation; Transplantation
  
• A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction after Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00106392 - Active, not recruiting
  Erectile Dysfunction; Prostate Cancer
  
• Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00472082 - Recruiting
  Kidney Transplantation; Chronic Kidney Failure
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00105001 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00296348 - Recruiting
  Kidney Transplantation
  
• Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
  ClinicalTrials.gov Identifier: NCT00260208 - Recruiting
  Liver Transplant; Hepatitis C
  
• To Compare the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
  ClinicalTrials.gov Identifier: NCT00371319 - Recruiting
  Lupus; Nephritis
  
• Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00089011 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• This Study is Designed to Evaluate Whether Tacrolimus Dose Reduction in de Novo Renal Recipients Receiving Everolimus Can Preserve Renal Function While Maintaining Efficacy.
  ClinicalTrials.gov Identifier: NCT00369161 - Recruiting
  Renal Transplantation
  
• A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00166556 - Recruiting
  Transplantation, Liver
  
• Tacrolimus (FK506) P-III Placebo-Controlled Double-Blind Study in Moderate to Severe Refractory Ulcerative Colitis Patients
  ClinicalTrials.gov Identifier: NCT00347048 - Recruiting
  Ulcerative Colitis
  
• Combining Chemotherapy, Tacrolimus, Mycophenolate Mofetil, and Radiation Therapy with Donor Bone Marrow Transplantation in Treating Patients with Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00049504 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Polymorphism of the Cytochrome P450-System and the MDR-System in Renal Transplants Receiving the Immunosuppressive Drugs Tacrolimus, Sirolimus, Everolimus or Cyclosporine A
  ClinicalTrials.gov Identifier: NCT00223054 - Recruiting
  Renal Transplantation
  
• Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00204191 - Recruiting
  Kidney Transplantation
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Immunodeficiency or Noncancerous Inherited Disorders
  ClinicalTrials.gov Identifier: NCT00358657 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00492869 - Recruiting
  Kidney Transplantation
  
• Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00302536 - Recruiting
  Focal Glomerulosclerosis
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• A Study to Compare Treatment with Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00005113 - Active, not recruiting
  End-Stage Renal Disease; Kidney Transplantation
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C